A NEW ERA FOR NMIBC: How a decade of progress is reshaping the treatment landscape.
| Publicado en: | Urology Times Vol. 53; no. 1; pp. 16 - 19 |
|---|---|
| Autor principal: | |
| Formato: | pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Jan2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=182580679&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 182580679 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00939722 URO jtl: Urology Times issn: 00939722 maglogo: N pubinfo: dt: Jan2025 vid: 53 iid: 1 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 182580679 182580679 182580679 182580679 ppf: 16 ppct: 3 formats: fmt: @attributes: type: P tig: atl: A NEW ERA FOR NMIBC: How a decade of progress is reshaping the treatment landscape. aug: au: Clarke, Hannah sug: subj: Non-Muscle Invasive Bladder Neoplasms Drug Therapy BCG Vaccine Therapeutic Use Immunotherapy Chemotherapy, Adjuvant Valrubicin Antibodies, Monoclonal Drug Development Patient Selection Clinical Trials Treatment Outcomes Survival Rate Translational Medical Research Drug Approval Urologists pubtype: Academic Journal doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|